Recombinant Mouse Prtn3 is generated using mammalian or insect cell systems to mimic native enzymatic activity:
Expression: Codon-optimized cDNA cloned into vectors under strong promoters (e.g., CMV or rEF1) .
Purification: Affinity chromatography (Ni-NTA for His-tagged proteins) followed by size-exclusion chromatography .
Storage: Stable at -80°C in buffers containing 10% glycerol; sensitive to freeze-thaw cycles .
Proteolytic Activity: Cleaves extracellular matrix proteins (elastin, collagen) and immune mediators like annexin A1, amplifying inflammation .
Neutrophil Survival: Transgenic mice expressing human Prtn3 (hPR3Tg) show delayed neutrophil apoptosis and increased peritoneal accumulation during sepsis .
Pathological Impact: Sustained Prtn3 activity correlates with tissue damage in models of peritonitis and sepsis .
HSPC Modulation: Prtn3 deficiency (Prtn3−/− mice) expands hematopoietic stem/progenitor cells (HSPCs) and enhances myeloid differentiation .
STAT3 Interaction: Prtn3 binds STAT3, promoting its ubiquitination and degradation, thereby inhibiting myeloid differentiation .
Prtn3 depletion protects against acute myeloid leukemia (AML) by restoring STAT3-dependent differentiation .
Prtn3−/− mice exhibit reduced leukemic burden in xenograft models .
Recombinant Mouse Prtn3 is widely used for:
Mechanistic approach:
Data contradiction analysis:
Solutions:
Approach: